St. Jude Medical (NYSE:STJ) finished the day with a nearly 8 percent jump in stock price after announcing the U.S. Food and Drug Administration approval of its long-awaited Unify Quadra cardiac resynchronization therapy defibrillator and Quartet Left Ventricular Quadripolar Pacing Lead.St. Jude’s stock closed at $38.44, up 7.7 percent over the previous day. But was [...]

St. Jude Medical Inc. (NYSE:STJ) yesterday announced U.S. Food and Drug Administration approval of its highly anticipated Unify Quadra cardiac resynchronization therapy defibrillator (CRT-D) and Quartet Left Ventricular Quadripolar Pacing Lead.This is the industry’s first quadripolar pacing system, which the St. Paul, Minnesota-based medical device maker says allows cardiologists to better manage CRT.Defibrillators are implanted [...]

Kensey Nash (NASDAQ: KNSY) , an Exton, Pennsylvania-based medical device company focused on regenerative medicine, saw year over year net income decline in the first three months of fiscal year 2012, driven by a $4 million drop in collagen product sales following a change to its contract with St Jude Medical (NYSE: STJ).Net income fell [...]

St. Jude Medical (NYSE:STJ) reported strong earnings and buyers responded, pushing the company’s stock price up 4.3 percent to $38.95. While profits were up notably, the focus is on St. Jude’s robust– albeit delayed– pipeline of products.Primarily, analysts and shareholders are eager for the delivery of Quadra, a slightly delayed cardiac therapy device that is [...]

St. Jude Medical (NYSE:STJ) this week rolled out one of its heart imaging products in India: the C7-XR Optical Coherence Tomography (OCT) Intravascular Imaging System with the C7 Dragonfly Imaging Catheter. It’s a natural addition to the St. Jude product line in the country. The imaging system is used by interventional cardiologists to help with [...]

Global medical device company St. Jude Medical announced the launch of the newest version of its Merlin.net Patient Care Network (PCN). The network organizes information about patient heart rhythms, device therapy and device performance, which is captured in implantable cardiac devices. It also allows the data to be sent directly to a clinic or hospital’s [...]

In the stockapocalypse that was Manic Monday, medical technology and pharma stocks got a mere slap on the wrist compared with banking stocks that received a more humiliating pants-down whipping.It appears that pharma stocks fared better than medical device and biotech stocks. GlaxoSmithKline (NYSE:GSK) was down a mere 28 cents to close at $39.44 on [...]

St. Jude Medical Inc. (NYSE:STJ) and Illumina Inc. (NSDQ:ILMN) both announced share repurchase programs this week after reporting second quarter earnings.St. Paul, Minn.-based St. Jude’s board of directors authorized up to $500 million to repurchase shares, which will be made available for general corporate purposes and for offsetting dilution associated [...]

The latest group purchasing organization deal by Upper Midwest Consolidated Services Center thumbs a nose at Medtronic’s (NYSE:MDT) controversial decision to cut several GPO deals earlier this year by replacing a Medtronic contract with a St. Jude Medical (NYSE:STJ) deal.Irving, Texas-based UMCSC announced a one-year contract for cardiac [...]

St. Jude Medical (NYSE:STJ) will lay off 450 people by the end of next year as it moves manufacturing of its cardiac rhythm management products from Sweden to Puerto Rico and Malaysia.